Trademark: 79343236
Word
EDIGENE
Status
Registered
Status Code
700
Status Date
Tuesday, November 21, 2023
Serial Number
79343236
Registration Number
7220512
Registration Date
Tuesday, November 21, 2023
Mark Type
4000
Filing Date
Friday, April 15, 2022
Published for Opposition
Tuesday, September 5, 2023

Trademark Owner History
EDIGENE INC. - Original Registrant

Classifications
5 Biological preparations for medical purposes for the treatment of gene mutation related diseases, hematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposes, namely, medicines for the treatment of diabetes, obesity, cancer, viral, metabolic, endocrine, musculoskeletal, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases and asthma, gastrointestinal diseases, genitourinary diseases, neurological diseases, allergies, headaches, insomnia, bacteria-based diseases, ocular disorders or diseases; pharmaceutical preparations, namely, antivirals, pharmaceutical preparations for suppressing tumors, pharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood products, namely, blood plasma, blood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical purposes; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; cord blood for medical purposes
42 Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research

Trademark Events
Mar 18, 2024
Final Decision Transaction Processed By Ib
Feb 22, 2024
Final Disposition Notice Sent To Ib
Feb 22, 2024
Final Disposition Processed
Feb 21, 2024
Final Disposition Notice Created, To Be Sent To Ib
Nov 21, 2023
Notice Of Registration Confirmation Emailed
Nov 21, 2023
Registered-Principal Register
Sep 5, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 5, 2023
Published For Opposition
Sep 4, 2023
Notification Processed By Ib
Aug 16, 2023
Notification Of Possible Opposition Sent To Ib
Aug 16, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 16, 2023
Notification Of Notice Of Publication E-Mailed
Jul 31, 2023
Approved For Pub - Principal Register
Jul 19, 2023
Teas/Email Correspondence Entered
Jul 18, 2023
Correspondence Received In Law Office
Jul 18, 2023
Teas Response To Office Action Received
Apr 19, 2023
Refusal Processed By Ib
Mar 29, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Mar 29, 2023
Refusal Processed By Mpu
Feb 4, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 3, 2023
Non-Final Action Written
Feb 2, 2023
Assigned To Examiner
Jun 28, 2022
Application Filing Receipt Mailed
Jun 24, 2022
New Application Office Supplied Data Entered
Jun 23, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24